Home
About Us
In this Issue
Previous Issue
Editorial Board
How to Contribute
Advertise with Us
Editorial Calendar
Subcribe Now
Global Healthcare Releases provided by Business Wire

 The Publication & Databases on Biotechnology in the Asia Pacific
 
 More free   feature articles 
  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

EDITORIAL

Public-private partnerships, or PPPs as they are more commonly referred to, are services or business ventures that are funded and operated through the partnership and collaboration of a private business company with a public company or the government of a country.

The products of the biotechnology industry are of great use and help to the nation and hence, both the public sector and the private sector benefit from any partnerships that can increase the efficiency and effectiveness of research in the biotechnology sector. One of the partnerships that some research laboratories enter to enable their research to become commercial products, are PPPs.

There are many small research laboratories working on what could potentially be ground-breaking research that would positively impact the lives of the people. However, without the proper funding and infrastructure, this research may not be able to reach the people. The public sector is able to provide the necessary infrastructure and funding to the private sector to enable them to more effectively and efficiently conduct their research. Hence, PPPs in the biotechnology industry allows them to work on and increase innovation in an area that is important for the general public. This helps both the research laboratory and the public sector.

For this issue, we have invited Dr. Alex Matter from Singapore’s Experimental Therapeutics Centre (ETC) to share about the different PPPs that the Agency of Science and Technology (A*STAR) of Singapore is involved in. We have also invited Irene Cheong from the National University of Singapore to share about the PPPs that the university is involved in. Lastly, we have Dr. Watson Ariyaphuttarat from Thailand’s KEEEN Ltd. and Duangkaew Chongkachornphong from BIOTEC in Thailand to share about a particularly successful PPP.

We do hope the issue is informative and interesting.


Rachel Lim
Editor
Asia Pacific Biotech News

Check out our new website at www.asiabiotech.com
Sign up for our mailing list to get updates at www.worldscientific.com/page/newsletter-sign-up
Air your views and suggestions by writing to in to the editorial team (Letters to the Editor) at biotech_edit@wspc.com

Click here for the complete issue.


About Us | How to Contribute | How to Advertise With Us | Contact Us |

"The views expressed here does not necessarily reflect the views of Asia Pacific Biotech News or its staff."
Copyright © 2014 World Scientific Publishing Co. All rights reserved.